Vaccine shot to keep JE at bay to become reality
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2014
Singapore: Chinese scientists have discovered a new vaccine for Japanese encephalitis that kills millions every year acr...Read more
Sinovac reports 7% decrease in sales
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 16 Nov, 2012
Singapore: Sinovac Biotech, a leading provider of vaccines in China, reported that its hepatitis vaccines sales in priva...Read more
Sanofi to supply 1.7 bn polio vaccines to GPEI
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 26 Apr, 2013
Bangalore: Sanofi Pasteur, the vaccines division of Sanofi, will provide 1.7 billion doses of oral polio vaccine (OPV) t...Read more
Dutch biotech firm raises $6.9 mn in China
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2014
Singapore: Clinical-stage Dutch biotechnology company, Mucosis has entered into a long-term collaboration and license ag...Read more
IVI appoints new board members
Vaccines | Influencers | By BioSpectrum Bureau | 0 Comment | 20 Nov, 2013
Singapore: South Korea-headquartered International Vaccine Institute (IVI) has appointed Professor Fred Binka, Dr Josep...Read more
Milestone payment for NTS vaccine project
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012
Bangalore: Bharat Biotech and The University of Maryland Center for Vaccine Development have received a $4 million strat...Read more
New antibodies against MERS: Saudi Arabia
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2014
Singapore: Saudi health officials declared that they had finally discovered new antibodies to combat the MERS virus. The...Read more
Eisai collaborates with Brazilian agency for vaccines
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2012
Singapore: Tokyo-headquartered Eisai has signed a global agreement with Brazil's Fundação Oswaldo Cruz for collabo...Read more
One third of world's unimmunized children in India
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2014
Singapore: Marking the start of the World Immunization Week, the Hilleman Laboratories, an equal joint-venture partnersh...Read more
Singapore's first flu vaccine clears phase I trial
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2014
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...Read more
Dr Vijay Datla to get FABA award at BioAsia 2013
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013
Hyderabad: Dr Vijay Kumar Datla, chairman and managing director of Biological E, will be given FABA Special Award 2013 ...Read more
How well is the industry prepared to fight H7N9 bird flu?
Vaccines | Analysis | By BioSpectrum Bureau | 2 Comment | 14 May, 2013
During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two mo...Read more
Major breakthrough in Hep C vaccine development
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2012
Singapore: Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could b...Read more
Biodiem develops killer for drug-resistant microbes
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...Read more
New drug to halt flu virus mutation
Vaccines | News | By Nandita Singh | 0 Comment | 11 Mar, 2013
A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the...Read more
Medicago, tobacco giant in vaccine deal for China
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: Medicago has granted Philip Morris Products (PMP) an exclusive license to develop, commercialize and manufact...Read more
Takeda to acquire Inviragen for $250 mn
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million...Read more
Allied has big plans for its HPV vaccine in 2013
Vaccines | Analysis | By BioSpectrum Bureau | 2 Comment | 02 Jan, 2013
Allied Healthcare Group's investment company, Coridon, which is led by Professor Ian Frazer, is in the process of develo...Read more